BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Staging
5 results:

  • 1. Serum cholesterol level as a predictive biomarker for prognosis of Neuroblastoma.
    Min J; Wu Y; Huang S; Li Y; Lv X; Tang R; Zhao H; Wang J
    BMC Pediatr; 2024 Mar; 24(1):205. PubMed ID: 38519890
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Angiogenic factors as prognostic markers in neuroendocrine neoplasms.
    Puliani G; Sesti F; Anastasi E; Verrico M; Tarsitano MG; Feola T; Campolo F; Di Gioia CRT; Venneri MA; Angeloni A; Appetecchia M; Lenzi A; Isidori AM; Faggiano A; Giannetta E;
    Endocrine; 2022 Apr; 76(1):208-217. PubMed ID: 35088292
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Development and Validation of a Modified Pathologic Nodal Classification System for Cutaneous Melanoma.
    Nguyen AT; Luu M; Nguyen VP; Hamid O; Faries MB; Gharavi NM; Lu DJ; Mallen-St Clair J; Ho AS; Zumsteg ZS
    JAMA Surg; 2021 Nov; 156(11):e214298. PubMed ID: 34468697
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Colon Neuroendocrine tumors: A New Lymph Node staging Classification.
    Fields AC; McCarty JC; Lu P; Vierra BM; Pak LM; Irani J; Goldberg JE; Bleday R; Chan J; Melnitchouk N
    Ann Surg Oncol; 2019 Jul; 26(7):2028-2036. PubMed ID: 30927196
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nodular Histologic Subtype and Ulceration are tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients.
    Faut M; Wevers KP; van Ginkel RJ; Diercks GF; Hoekstra HJ; Kruijff S; Been LB; van Leeuwen BL
    Ann Surg Oncol; 2017 Jan; 24(1):142-149. PubMed ID: 27646020
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.